Biological characteristics of sensitization in patients with MIRI
- Conditions
- Myocardial ischemia reperfusion injury
- Registration Number
- ChiCTR2400088845
- Lead Sponsor
- Shaanxi University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
MIRI patients:<br>(1) meeting the diagnostic criteria of non-ST elevation acute coronary syndrome in 2023 ESC Guidelines for the management of acute coronary syndromes.<br>(2) received percutaneous coronary intervention within a week.<br>(3) aged 18 to 85 years.<br>(4) willing to participate in this study, and sign on informed consent.<br>Healthy subjects:<br>(1) received a health examination within a week, and confirmed to be in good health.<br>(2) aged 18 to 85 years.<br>(3) willing to participate in this study, and sign on informed consent.
(1) diagnosed as ST-elevation myocardial infarction, with persistent ST-segment elevation or ST-segment elevation equivalents on electrocardiogram.<br>(2) combined with disorders of rhythm, disorders of the heart, muscles, valves, and pericardium, and peripheral vascular disease.<br>(3) suffering from neoplastic disorders, hematopoietic disorders, disorders of hemostasis, infectious diseases, immune-mediated, inflammatory, and rheumatologic disorders.<br>(4) combined with fever.<br>(5) suffering from psychiatric disorders, and unable to cooperate.<br>(6) participating in any other study within 3 months.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mRNA;
- Secondary Outcome Measures
Name Time Method